雾化吸入布地奈德混悬液治疗急性感染性喉炎患儿的临床观察

发布时间：2018-08-06 22:01

【摘要】：目的探讨雾化吸入布地奈德混悬液治疗急性感染性喉炎的临床效果,为临床选择有效药物提供依据。方法选取2014年10月-2015年9月在医院儿科诊断为急性感染性喉炎的患儿120例为研究对象,随机将患儿分为观察组60例与对照组60例,两组患者均给予常规的支持治疗和对症治疗;观察组给予布地奈德混悬液雾化吸入治疗,对照组给予地塞米松进行治疗。结果观察组患者呼吸困难、喉鸣音、咳嗽及声嘶消失时间均短于对照组患者,差异均有统计学意义(P0.05);患者治疗总有效率观察组为98.33%、对照组为86.67%,观察组明显高于对照组,差异有统计学意义(P0.05);观察组患者不良反应发生率为6.67%、对照组为8.33%,差异无统计学意义。结论雾化吸入布地奈德混悬液治疗急性感染性喉炎的临床效果显著,不良反应率低,临床症状消失时间短。
[Abstract]:Objective to investigate the clinical effect of inhaled budesonide suspension in the treatment of acute infectious laryngitis. Methods from October 2014 to September 2015, 120 children with acute infectious laryngitis were randomly divided into observation group (n = 60) and control group (n = 60). The observation group was treated with budesonide suspension aerosol inhalation and the control group with dexamethasone. Results the time of dyspnea, larynx sound, cough and hoarseness in the observation group was shorter than that in the control group (P0.05), the total effective rate of treatment was 98.33 in the observation group and 86.67 in the control group, which was significantly higher in the observation group than in the control group. The incidence of adverse reactions was 6.67 in the observation group and 8.33 in the control group. Conclusion the efficacy of inhaled budesonide suspension in the treatment of acute infectious laryngitis is significant, the adverse reaction rate is low, and the clinical symptom disappearance time is short.
【作者单位】：海口市妇幼保健院药剂科;海口市妇幼保健院保健部;海口市妇幼保健院儿科;海口市妇幼保健院儿保科;
【基金】：海南省科技厅卫生科研基金资助项目(811142)
【分类号】：R767.11

【相似文献】